NCR3 and neoplasm: PD-1 blockade was also shown to significantly increase not only the expression of NK cell-activating receptors NK2GD, NKp44 and NKp30 [220], but also CXCR4 expression on NK cells and the formation of immune complexes between anti-PD-1-treated NK cells and tumor cells [221].